Back

Post-Receptor Dissociation of Estrogen Signaling in Macrophage-Infiltrated Meningiomas: A Multi-Method Deconvolution Study of 968 Transcriptomes

Piccolo, D.; Vindigni, M.

2026-05-21 oncology
10.64898/2026.05.19.26353588 medRxiv
Show abstract

Background. Meningiomas exhibit well-established hormonal biology, yet no study has examined whether myeloid immune infiltration interacts with estrogen-responsive transcription in this tumor type. Methods. We applied three-method consensus immune deconvolution (EPIC, MCPcounter, CIBERSORTx) to 968 harmonized meningioma RNA-seq transcriptomes from five public datasets, stratified by Thirimanne et al. (2024) transcriptomic subtypes. Competitive gene set enrichment compared macrophage-high versus macrophage-low tertiles with sex-adjusted, purity-adjusted, and method-independent sensitivity analyses. Survival modeling tested both total macrophage burden and a decomposed microglia-to-macrophage ratio validated against single-cell ground truth (pseudo-bulk r = 0.77). Results. Macrophage-high tumors showed significant suppression of estrogen response gene sets (FDR = 4.9 x 10-5) despite paradoxical ESR1 upregulation (log2FC = +0.40, FDR = 2.5 x 10-26) and PGR downregulation (log2FC = -0.34, FDR = 2.7 x 10-3), indicating post-receptor transcriptional disruption. This signal strengthened after sex adjustment (FDR = 1.9 x 10-6) and was confirmed across a multi-layer sensitivity battery (eleven analyses including reference-matrix-independent, purity-adjusted, rotation-based self-contained, and empirical-null tests; all FDR < 3 x 10-4 in the relevant convergent tests). Myeloid infiltration was strongly subtype-dependent (Kruskal-Wallis p = 7.4 x 10-16) but grade-independent (p = 0.399), with CSF1R enriched in the macrophage-dominant Cluster B. Neither total macrophage score (HR = 0.90, p = 0.53; N = 102) nor a decomposed microglia/macrophage ratio (HR = 0.92, p = 0.46; N = 101) predicted recurrence-free survival. Conclusions. The pre-registered primary endpoint - macrophage infiltration score predicting recurrence-free survival - was not supported; the estrogen-immune dissociation emerged from secondary exploratory gene-set analysis and requires independent validation. Macrophage-infiltrated meningiomas exhibit a previously unreported dissociation between maintained ESR1 expression and suppressed estrogen-responsive transcription, with implications for hormonal therapy stratification.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Clinical Cancer Research
64 papers in training set
Top 0.1%
11.8%
2
Journal of Neuro-Oncology
10 papers in training set
Top 0.1%
6.7%
3
Nature Communications
5641 papers in training set
Top 24%
6.7%
4
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 8%
5.5%
5
Cancers
213 papers in training set
Top 1%
5.4%
6
Breast Cancer Research
36 papers in training set
Top 0.2%
4.3%
7
Scientific Reports
3612 papers in training set
Top 24%
4.3%
8
Cell Reports
1498 papers in training set
Top 10%
4.0%
9
eLife
5828 papers in training set
Top 30%
4.0%
50% of probability mass above
10
Communications Medicine
113 papers in training set
Top 1%
3.2%
11
International Journal of Cancer
49 papers in training set
Top 0.4%
2.7%
12
Acta Neuropathologica
58 papers in training set
Top 0.6%
2.4%
13
Cancer Research
130 papers in training set
Top 2%
1.9%
14
JAMA Network Open
130 papers in training set
Top 2%
1.7%
15
Cancer Cell
42 papers in training set
Top 0.7%
1.7%
16
Molecular Oncology
55 papers in training set
Top 0.7%
1.7%
17
The American Journal of Human Genetics
234 papers in training set
Top 2%
1.1%
18
Communications Biology
993 papers in training set
Top 22%
1.1%
19
Neuro-Oncology Advances
25 papers in training set
Top 0.4%
1.1%
20
Neuro-Oncology
36 papers in training set
Top 0.5%
1.1%
21
Frontiers in Oncology
103 papers in training set
Top 3%
1.1%
22
British Journal of Cancer
49 papers in training set
Top 1%
1.1%
23
PLOS ONE
5266 papers in training set
Top 57%
1.1%
24
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 2%
1.0%
25
Science Translational Medicine
127 papers in training set
Top 3%
1.0%
26
JNCI: Journal of the National Cancer Institute
19 papers in training set
Top 0.3%
0.9%
27
Acta Neuropathologica Communications
89 papers in training set
Top 2%
0.8%
28
Cell Reports Medicine
153 papers in training set
Top 5%
0.8%
29
International Journal of Molecular Sciences
494 papers in training set
Top 15%
0.8%
30
Frontiers in Immunology
638 papers in training set
Top 11%
0.6%